{"title":"<i>Pseudomonas Mendocina</i> Bacteraemia Secondary to Cellulitis - A Report and Brief Series of Cases.","authors":"Jorge Reis, Francisca Carmo, Inês Soares, Catarina Salvado, Mariana Fidalgo","doi":"10.12890/2025_005094","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Pseudomonas mendocina</i> is a rare cause of disease in humans with few cases described, but known to cause severe infections, mainly endocarditis and bacteraemia.</p><p><strong>Case description: </strong>An 86-year-old Caucasian male, with several vascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, coronary heart disease and heart failure), who presented long-standing lower limb phlyctens for which he was being treated, developed lower limb cellulitis. When observed in the Emergency Department, he was septic and was admitted for treatment and surveillance. Blood cultures were positive for <i>P. mendocina</i>. He was treated with antibiotics and recovered, and was discharged home.</p><p><strong>Conclusion: </strong>Damage to the skin barrier as in cellulitis provides a point of entry for <i>P. mendocina</i>, a microorganism that lives in soil and water. The source of contamination is rarely identified, but immunocompromised people present a higher risk of infection and severe disease. The antibiotic susceptibility profile is different from the more common <i>Pseudomonas aeruginosa</i>, with fewer known resistances. Albeit rare, this is thought to be an underreported infection that clinicians should be aware of.</p><p><strong>Learning points: </strong>Infection by <i>Pseudomonas mendocina</i> is rare but potentially life-threatening.Its true prevalence is unknown due to underreporting.Immunocompromised patients seem more at risk for infection by this pathogen.</p>","PeriodicalId":11908,"journal":{"name":"European journal of case reports in internal medicine","volume":"12 2","pages":"005094"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801501/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of case reports in internal medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12890/2025_005094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pseudomonas mendocina is a rare cause of disease in humans with few cases described, but known to cause severe infections, mainly endocarditis and bacteraemia.
Case description: An 86-year-old Caucasian male, with several vascular risk factors (type 2 diabetes, hypertension, dyslipidaemia, coronary heart disease and heart failure), who presented long-standing lower limb phlyctens for which he was being treated, developed lower limb cellulitis. When observed in the Emergency Department, he was septic and was admitted for treatment and surveillance. Blood cultures were positive for P. mendocina. He was treated with antibiotics and recovered, and was discharged home.
Conclusion: Damage to the skin barrier as in cellulitis provides a point of entry for P. mendocina, a microorganism that lives in soil and water. The source of contamination is rarely identified, but immunocompromised people present a higher risk of infection and severe disease. The antibiotic susceptibility profile is different from the more common Pseudomonas aeruginosa, with fewer known resistances. Albeit rare, this is thought to be an underreported infection that clinicians should be aware of.
Learning points: Infection by Pseudomonas mendocina is rare but potentially life-threatening.Its true prevalence is unknown due to underreporting.Immunocompromised patients seem more at risk for infection by this pathogen.
期刊介绍:
The European Journal of Case Reports in Internal Medicine is an official journal of the European Federation of Internal Medicine (EFIM), representing 35 national societies from 33 European countries. The Journal''s mission is to promote the best medical practice and innovation in the field of acute and general medicine. It also provides a forum for internal medicine doctors where they can share new approaches with the aim of improving diagnostic and clinical skills in this field. EJCRIM welcomes high-quality case reports describing unusual or complex cases that an internist may encounter in everyday practice. The cases should either demonstrate the appropriateness of a diagnostic/therapeutic approach, describe a new procedure or maneuver, or show unusual manifestations of a disease or unexpected reactions. The Journal only accepts and publishes those case reports whose learning points provide new insight and/or contribute to advancing medical knowledge both in terms of diagnostics and therapeutic approaches. Case reports of medical errors, therefore, are also welcome as long as they provide innovative measures on how to prevent them in the current practice (Instructive Errors). The Journal may also consider brief and reasoned reports on issues relevant to the practice of Internal Medicine, as well as Abstracts submitted to the scientific meetings of acknowledged medical societies.